What is Simulands?
Simulands, headquartered in Switzerland, is a provider of advanced medical training simulation equipment. The company focuses on delivering realistic and effective tools for healthcare professionals to enhance their skills and patient care outcomes. The recent enterprise-level funding indicates a strong market appetite for innovative solutions in medical education and training.
How much funding has Simulands raised?
Simulands has raised a total of $10.5M across 1 funding round:
Other Financing Round
$10.5M
Other Financing Round (2023): $10.5M with participation from SHS Group
Key Investors in Simulands
SHS Group
SHS Group, a UK-based entity with a history dating back to 1975, typically focuses on food and beverage sectors. Their participation in this funding round suggests a potential diversification strategy or a strategic interest in the burgeoning medical technology market.
What's next for Simulands?
The substantial enterprise-level funding and recent strategic investment suggest Simulands is poised for significant expansion and further development of its simulation technologies. This capital infusion will likely fuel research and development, enhance manufacturing capabilities, and broaden market reach, solidifying its role as a key player in the medical simulation industry.
See full Simulands company page
